Story perspectives

Insurers Drop GLP-1 Coverage, Leaving Patients Paying $1,000

By Drooid · Oct 6, 2026, 4:02 AM UTC · How we work

Summary

Story summary

One in eight U.S. residents are now taking GLP-1 drugs, according to PBS NewsHour.
Many insurers have dropped coverage, forcing some patients to pay over $1,000 monthly.
CMS programs can reduce the monthly cost to $50 for eligible patients.
Serena Williams said GLP-1 medication helped her lose 31 pounds.
Industry analysts estimate the global GLP-1 market could reach $200 billion by 2030.

1 of 1

Story summary

One in eight U.S. residents are now taking GLP-1 drugs, according to PBS NewsHour.
Many insurers have dropped coverage, forcing some patients to pay over $1,000 monthly.
CMS programs can reduce the monthly cost to $50 for eligible patients.
Serena Williams said GLP-1 medication helped her lose 31 pounds.
Industry analysts estimate the global GLP-1 market could reach $200 billion by 2030.